Since the introduction of transjugular intrahepatic portosys-temic shunt (T
IPS) 10 years ago, it has been used increasingly in the management nf porta
l hypertension and its complication TIPS is now considered the procedure of
choice for management nf refractory variceal bleeding. Its role in the man
agement of refractory ascites, hepatic hydrothorax, hepatorenal syndrome, a
nd hepatopulmonary syndrome still awaits further prospective studies. The t
wo main complications of TIPS are hepatic encephalopathy and shunt malfunct
ion. Generally, TIPS stenosis or occlusion is a major drawback requiring ro
utine surveillance of TIPS with doppler ultrasound. Venography with balloon
dilation of the stent or placement of serial or parallel stents may be req
uired in some cases. Promising modalities of preventing TIPS malfunction (e
.g., brachytherapy, covered stents, or anti-platelet derived growth factor)
are currently being investigated.